Achieved additional $75 million in partnering proceeds from Sanofi and GileadGranted license to additional preclinical program to Gilead that leverages MacroGenics’ novel T-cell engager ...

TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the three months ended September ...

Tis the season when families with high school seniors are checking their list ? their college list ? twice. With many college applications for early action due in the coming weeks ? and applications ...

Hidden in North Laurel, Maryland exists a bargain hunter’s nirvana that might have you checking your receipt twice, wondering how you just walked out with three bags of treasures for less than the ...